[Oxygen, phagocytic cells and atheroma].

Area of Science:

• Cardiovascular Biology
• Immunology
• Cell Biology

Context:

• Atherosclerosis is a complex disease involving endothelial dysfunction, inflammation, and lipid accumulation.
• Phagocytes and reactive oxygen species (ROS) are implicated in the early stages of atherosclerosis.
• Endothelial cell damage is a critical factor in the development of atherosclerotic lesions.

Purpose:

• To explore the roles of phagocytes and ROS in the initiation and progression of atherosclerosis.
• To investigate the mechanisms by which phagocytes and ROS contribute to endothelial cell damage and lipid peroxidation.
• To understand the formation and impact of modified low-density lipoproteins (LDL) in atherosclerosis.

Summary:

• Phagocytes (neutrophils, monocytes, macrophages) and ROS can directly damage endothelial cells, initiating atherosclerotic processes.
• ROS contribute to the formation of cytotoxic lipoperoxides within LDL particles, leading to modified LDL.
• Modified LDL are recognized by scavenger receptors on macrophages, promoting foam cell formation and further ROS production.
• Endothelial cell damage increases vascular permeability, attracts immune cells, and reduces protective factors like prostacyclin, amplifying lipid peroxidation and vascular wall damage.

Impact:

• Provides in vitro evidence for the involvement of ROS and phagocytes in endothelial damage and lipid peroxidation, key mechanisms in atherosclerosis.
• Highlights the critical role of modified LDL and immune responses in the pathogenesis of atherosclerosis.
• Suggests potential therapeutic targets related to controlling phagocyte activity and oxidative stress in preventing or treating atherosclerosis.